Sonia Servitja

4PUBLICATIONS
43CO-AUTHORS
Molecular targetsBiomechanical engineeringPredictive and prognostic markersEpidemiological methods
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Dec 01, 2025
Addition of Ipatasertib to Dual Anti-HER2 Maintenance Therapy in HER2-Positive Metastatic Breast Tumors with PIK3CA Mutations: The Phase Ib SOLTI-1507 IPATHER Trial.

Mafalda Oliveira, Eva Ciruelos, Guillermo Villacampa

|Aug 02, 2025
Economic impact of MAF testing for adjuvant bisphosphonate therapy in early breast cancer: a multi-regional budget impact analysis from a payer perspective.

João L Carapinha, Juan Carlos Tercero, Ralf van den Berg

|Jul 09, 2025
Transcriptomic Predictors of Survival for Palbociclib + Endocrine Therapy Versus Capecitabine in Aromatase Inhibitor-Resistant Breast Cancer From the GEICAM/2013-02 PEARL Trial.

Yash N Agrawal, Aranzazu Fernández-Martínez, Miguel Gil-Gil

|Jan 25, 2025
Evaluating the Quality of Real-World Data on Adherence to Oral Endocrine Therapy in Breast Cancer Patients: How Real Is Real-World Data?

A Navarro-Sabaté, R Font, J A Espinàs

Pageof 1

Frequent Collaborators

2 joint publications

Miguel Gil-Gil

2 joint publications

Eva María Ciruelos

1 joint publications

A Navarro-Sabaté

1 joint publications

J A Espinàs